HCID 49758714, compound → HCID 58485303, compound

HRID 1046093Notes

Reaction equation

HRID 1046093 reaction equation
[OH:1][C:2]([CH3:35])([CH3:34])[CH2:3][C@@:4]1([C:28]2[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=2)[O:9][C:8](=[O:10])[N:7]([C@H:11]([C:13]2[CH:18]=[CH:17][C:16](B3OC(C)(C)C(C)(C)O3)=[CH:15][CH:14]=2)[CH3:12])[CH2:6][CH2:5]1.Br[C:37]1[CH:38]=[N:39][C:40]([N:43]2[CH:47]=[CH:46][N:45]=[C:44]2[CH3:48])=[N:41][CH:42]=1>>[OH:1][C:2]([CH3:34])([CH3:35])[CH2:3][C@@:4]1([C:28]2[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=2)[O:9][C:8](=[O:10])[N:7]([C@H:11]([C:13]2[CH:14]=[CH:15][C:16]([C:37]3[CH:38]=[N:39][C:40]([N:43]4[CH:47]=[CH:46][N:45]=[C:44]4[CH3:48])=[N:41][CH:42]=3)=[CH:17][CH:18]=2)[CH3:12])[CH2:6][CH2:5]1

Participants

3

Procedure

The title compound was prepared from (S)-6-(2-hydroxy-2-methylpropyl)-6-phenyl-3-((S)-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)-1,3-oxazinan-2-one and 5-bromo-2-(2-methyl-1H-imidazol-1-yl)-pyrimidine following a procedure analogous to that described in Example 1 Step 2. LC-MS Method 2 tR=0.932 min, m/z=512.3; 1H NMR (CD3OD) 0.86 (s, 3H), 1.16 (s, 3H), 1.49 (m, 3H), 2.15 (m, 2H), 2.18 (m, 1H), 2.37-2.49 (m, 2H), 2.79 (s, 3H), 3.03 (m, 1H), 5.53 (m, 1H), 7.01-7.06 (m, 3H), 7.21-7.29 (m, 5H), 7.44 (m, 2H), 7.97 (m, 1H), 8.95 (s, 2H).

Sources & evidence

ORD record
ord-b60a20da5d344790ba4df1718c746778
Source dataset
uspto-grants-2013_10
Patent number
US08569292B2

Reaction notes

Loading…